Exhibit 99.1
------------
AMENDED AND RESTATED JOINT FILING AGREEMENT
PURSUANT TO RULE 13d-1(k)(1)
----------------------------
The undersigned acknowledge and agree that the foregoing statement on
Schedule 13D is filed on behalf of each of the undersigned and that all
subsequent amendments to this statement on Schedule 13D shall be filed on behalf
of each of the undersigned without the necessity of filing additional joint
filing agreements. The undersigned acknowledge that each shall be responsible
for the timely filing of such amendments, and for the completeness and accuracy
of the information concerning it contained therein, but shall not be responsible
for the completeness and accuracy of the information concerning the others,
except to the extent that it knows or has reason to believe that such
information is inaccurate. This Agreement may be executed in any number of
counterparts and all of such counterparts taken together shall constitute one
and the same instrument. This Amended and Restated Joint Filing Agreement amends
and restates in its entirety that certain Joint Filing Agreement, dated as of
March 5, 2007, originally filed with the Original 13D.
Dated: March 21, 0000
XXXXX XXXXX LLC
By: Xxxxxx X. Xxxx,
Chief Executive Officer
By: /s/ Xxxxxx Xxxxxx
-------------------------------
Name: Xxxxxx Xxxxxx
Title: Attorney-in-Fact
THIRD POINT OFFSHORE FUND, LTD.
By: Xxxxxx X. Xxxx,
Director
By: /s/ Xxxxxx Xxxxxx
-------------------------------
Name: Xxxxxx Xxxxxx
Title: Attorney-in-Fact
XXXXXX X. XXXX
By: /s/ Xxxxxx Xxxxxx
-------------------------------
Name: Xxxxxx Xxxxxx
Title: Attorney-in-Fact
/s/ Xxxxx Xxxxx
-----------------------------------
Xxxxx Xxxxx
[AMENDED AND RESTATED JOINT FILING AGREEMENT FOR SCHEDULE 13D
WITH RESPECT TO PDL BIOPHARMA, INC.]
